Guide Therapeutics, Inc.

Amendment
CIK: 0001769132·Other Technology·DELAWARE·Filed: Apr 25, 2019
Total Offering

$6,000,000

Amount Sold

$6,000,000

Investors

2

First Sale

Feb 15, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Thomas Reese Saylor
Related Person
James Dahlman
Related Person
Andrew Perlman
Related Person
Boris Nikolic
Related Person

Company

Guide Therapeutics, Inc.

308 NORTHYARDS BLVD.

ATLANTA, GA, 30013

404-937-3801

SEC Filing

0001769132-19-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Guide Therapeutics, Inc. Form D Filing — $6,000,000 | FilingFlow